Gagnon Securities’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,114
Closed -$289K 99
2017
Q3
$289K Sell
2,114
-78
-4% -$11.8K 0.11% 72
2017
Q2
$385 Sell
2,192
-6,675
-75% -$949K 0.11% 59
2017
Q1
$1.06M Buy
8,867
+149
+2% +$15.5K 0.46% 40
2016
Q4
$850K Sell
8,718
-8
-0.1% -$733 0.36% 47
2016
Q3
$819K Sell
8,726
-39
-0.4% -$3.91K 0.35% 48
2016
Q2
$944K Hold
8,765
0.44% 40
2016
Q1
$1.05M Buy
8,765
+1,528
+21% +$160K 0.5% 37
2015
Q4
$862K Buy
7,237
+1,186
+20% +$153K 0.39% 42
2015
Q3
$1.03M Sell
6,051
-1,363
-18% -$261K 0.5% 34
2015
Q2
$1.44M Sell
7,414
-36,816
-83% -$6.83M 0.57% 29
2015
Q1
$6.55M Sell
44,230
-17,137
-28% -$2.61M 2.17% 16
2014
Q4
$9.57M Sell
61,367
-3,417
-5% -$492K 3.07% 14
2014
Q3
$9.29M Sell
64,784
-965
-1% -$140K 3.1% 14
2014
Q2
$8.58M Sell
65,749
-2
-0% -$254 2.78% 15
2014
Q1
$8.05M Buy
65,751
+645
+1% +$69.9K 2.39% 17
2013
Q4
$6.91M Buy
65,106
+1,885
+3% +$183K 2.08% 20
2013
Q3
$7.09M Sell
63,221
-2,436
-4% -$276K 2.21% 19
2013
Q2
$7.41M Buy
+65,657
New +$8.03M 2.68% 18

Other funds holding SRGA

Gagnon Securities's SRGA Position: Q4 2017 in Review

Gagnon Securities sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2017, closing a stake of 2,114 shares — an estimated $289K sold.

Gagnon Securities first reported a position in SRGA in Q2 2013 and held it in 18 quarters. The position peaked at $9.57M in Q4 2014. 109 funds tracked by Wall St. Rank hold SRGA as of Q4 2017.

  • Gagnon Securities reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Gagnon Securities sold 2,114 Surgalign Holdings, Inc. Common Stock shares in Q4 2017, an estimated $289K.
  • Gagnon Securities first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
  • Gagnon Securities's Surgalign Holdings, Inc. Common Stock position peaked at $9.57M in Q4 2014.
  • 109 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2017.

Based on Gagnon Securities's 13F filing for Q4 2017, filed 13 Feb 2018.